7358
J. Boruwa et al. / Tetrahedron Letters 45 (2004) 7355–7358
MS (ESI) m/z = 258.0(M ++Na). Compound 8a. IR
(chloroform, cmꢀ1): 3408, 2931, 2103, 1443, 1279,
1104, 944, 873, 771. 1H NMR (300MHz, CDCl3)
d = 7.21 (5H), 4.22 (d, J = 6Hz, 1H), 3.59 (m, 1H),
3.28 (d, J = 2.6Hz, 1H), 2.08 (br s, 1H). MS (ESI)
chromatography over silica gel using ethylacetate/petro-
leum ether as eluent.
Acknowledgements
+
m/z = 216.0(M +Na).
The authors are thankful to Director R. R. L. Jorhat for
providing facilities.
20
(2S,3R)-11: Solid; mp: 72–73ꢁC; ½a ꢀ6:1 (c 1 metha-
D
nol); ee: 99%. IR (chloroform, cmꢀ1): 3449, 2982,
2937, 2838, 1735, 1613, 1514, 1465, 1389, 1370, 1302,
1249, 1178, 1031, 834, 771. 1H NMR (300MHz, CDCl3)
d = 7.38 (d, J = 8.5Hz, 2H), 6.84 (d, J = 8.5Hz, 2H),
4.92 (d, J = 5.5Hz, 1H), 4.12 (q, J = 4.4Hz, 2H), 3.85
(s, 3H), 3.25 (d, J = 5.5Hz, 1H), 2.85 (br, 1H), 1.35 (t,
J = 7.17Hz, 3H). MS (ESI) m/z = 263.0(M ++Na). 13C
NMR (75MHz, CDCl3) d = 13.09, 54.29, 61.11, 73.23,
73.8, 112.8, 124.89, 126.62, 131.07, 158.35, 171.80. Anal.
Calcd for C12H16O5: C, 59.99; H, 6.71. Found: C, 59.80;
H, 6.88.
References and notes
1. Schuberet, J.; Schwesinger, R.; Prizbach, H. Angew.
Chem., Int. Ed. Engl. 1994, 23, 167–169.
2. Scriven, E. F. V.; Turnbull, K. Chem. Rev. 1988, 88,
297–368.
3. Katsuki, T.; Sharpless, K. B. J. Am. Chem. Soc. 1980, 102,
5976–5978.
4. Jacobsen, E. N.; Marko, I.; Mungall, S.; Schroder, G.;
Sharpless, K. B. J. Am. Chem. Soc. 1988, 110, 1968–
1970.
5. (a) The Chemistry of Azido Group; Patal, S., Ed.; Wiley:
New York, 1971; (b) Nugent, T. C.; Hudlicky, T. J. Org.
Chem. 1998, 63, 510–520.
6. (a) Fringuelli, F.; Piermatti, O.; Pizzo, F.; Vaccaro, L. J.
Org. Chem. 2001, 64, 6094–6096; (b) Fringuelli, F.;
Piermatti, O.; Pizzo, F.; Vaccaro, L. J. Org. Chem. 2001,
66, 4719–4722.
7. (a) Nugent, W. A. J. Am. Chem. Soc. 1992, 114,
2768–2769; For review: (b) Paterson, L.; Barrisford, D.;
Organic, J. In Synthesis Highlights III; Mulzer, C.,
Waldmann, H., Eds.; Wiley: VCH, 1998.
8. Schnieder, C. Synlett, 2000, 1840–1842.
9. Sen, S. E.; Smith, S. M.; Sullivan, K. A. Tetrahedron 1999,
55, 12657–12698.
20
(2S,3R)-12: Solid; mp 97–98ꢁC; ½a ꢀ46 (c 1 metha-
D
nol); ee: 98%. IR (chloroform, cmꢀ1): 3426, 3025,
2930, 1742, 1614,1514, 1370, 1250, 1176, 1030, 882,
767. 1H NMR (300MHz, CDCl3) d = 7.57 (d,
J = 8.2Hz, 2H), 7.19 (d, J = 8.1Hz, 2H), 7.10(d,
J = 8.6Hz, 2H), 6.71 (d, J = 8.6Hz, 2H), 4.98
(d, J = 4.9Hz, 1H), 4.76 (d, J = 5Hz, 1H), 4.03 (q,
J = 7Hz, 2H), 3.75 (s, 3H), 2.82 (br, 1H), 2.41 (s, 3H),
0.98 (t, J = 7Hz, 3H). MS (ESI) m/z = 417.1 (M++Na).
13C NMR (75MHz, CDCl3) d = 12.81, 20.63, 54.05,
60.81, 72.26, 75.59, 76.01, 76.44, 80.57, 95.13, 112.64,
126.65, 127.00, 128.48, 128.55, 131.79, 143.67, 158.57,
165.88.
10. Kalita, B.; Bezbarua, M. S.; Barua, N. C.; Bez, G. Synlett,
2001, 1411–1414.
11. Paquette, L. A., Ed. Encyclopaedia of Reagents for
Organic Synthesis; John Wiley & Sons, 1995; Vol. 5, pp
3646.
12. Kakeya, H.; Morishita, M.; Kobinata, K.; Osono, M.;
Ishizuka, M.; Osada, H. J. Antibiot. 1998, 51, 1126–1128.
13. Kakeya, H.; Morishita, M.; Koshino, H.; Morita, T.;
Kobayashi, K.; Osada, H. J. Org. Chem. 1999, 64,
1052–1053.
14. (a) Sakamoto, Y.; Shiraishi, A.; Soenhee, J.; Nakata, T.
Tetrahedron Lett. 1999, 40, 4203–4206; (b) Hamersak, Z.;
Ljubovic, E.; Mercep, M.; Mesic, M.; Sunjic, V. Synthesis,
2001, 1989–1992; (c) Vanketeswara Rao, B.; Madhan, A.;
Kumar, R. Tetrahedron: Asymmetry 2001, 12, 2009–2011;
(d) Miyata, O.; Asai, H.; Naito, T. Synlett 1999,
1915–1916.
20
(2R,3S)-13: Gum; ½a þ9:1 (c 0.8, chloroform); ee:
D
98%. IR (chloroform, cmꢀ1): 2926, 2936, 2838, 1733,
1612, 1513, 1463, 1301, 1249, 1111, 1030, 833. 1H
NMR (300MHz, CDCl3) d = 7.31 (d, J = 8.5Hz, 2H),
6.88 (d, J = 8.5Hz, 2H), 4.24 (d, J = 7Hz, 1H), 4.02
(q, J = 7Hz, 1H), 3.82 (d, J = 4.7Hz, 1H), 3.70(s,
3H), 1.30(t, J = 7Hz, 3H). MS (ESI) m/z = 222.0
(M+). Anal. Calcd for C12H14O4: C, 64.85; H, 6.35.
Found: C, 64.63; H, 6.12.
20
(2S,3R)-14: Liquid; ½a ꢀ23 (c 1.0chloroform); ee:
D
98%. IR (chloroform, cmꢀ1): 3490, 2965, 2107, 1744,
1612, 1514, 1428, 1252, 1213, 1131, 1028, 827. 1H
NMR (300MHz, CDCl3) d = 7.30(d, J = 8.5Hz, 2H),
6.88 (d, J = 8.5Hz, 2H), 4.85 (d, J = 2.7Hz, 1H), 4.23
(q, J = 7Hz, 2H), 3.75 (s, 3H), 3.08 (d, J = 6.7Hz,
1H), 1.30(t, J = 7Hz, 3H). MS (ESI) m/z = 265.1
(M+). 13C NMR (75MHz, CDCl3) d = 12.82, 54.60,
56.73, 67.45, 77.51, 77.45, 77.85, 112.81, 125.49,
127.13, 156.43, 168.29. Anal. Calcd for C12H15O4N3:
C, 54.33; H, 5.70; N, 15.84. Found: C, 54.49; H, 5.83;
N, 15.97.
15. The enantiomeric excess (ee) was measured by HPLC
analysis carried out on a Waters 510HPLC system.
Chiracel OD packed in
a SS column of 4.6mm
i.d. · 250mm dimension was used. Isocratic elution was
applied with a mobile phase n-hexane 90% and isopropa-
nol 10% at a flow rate 0.8mL/min, and pressure 125psi.
UV was monitored at 243nm.
16. Denis, J.-N.; Correa, A.; Green, A. E. J. Org. Chem. 1990,
55, 1957–1959.
17. Flemming, P. R.; Sharpless, K. B. J. Org. Chem. 1991, 56,
2869–2875.
18. Hoffman, R. V.; Kim, H. J. Org. Chem. 1991, 56,
6759–6764.
19. (a) Caron, M.; Sharpless, K. B. J. Org. Chem. 1985, 50,
1557–1560; (b) Caron, M.; Carlier, R. R.; Sharpless, K. B.
J. Org. Chem. 1988, 53, 5185–5187.
General method for epoxide ring opening: NaN3 in 2mL
˚
CH3CN were added to powdered 4A molecular sieves
(100mg) and the mixture stirred for specific time. The
reaction mixture was then filtered, the filter pad was
washed with CH3CN and the combined filtrates was
evaporated. The crude product was then purified by